<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00762060</url>
  </required_header>
  <id_info>
    <org_study_id>MISScolorectal</org_study_id>
    <nct_id>NCT00762060</nct_id>
  </id_info>
  <brief_title>Multicenter Infection Surveillance Study Following Colorectal Procedures</brief_title>
  <acronym>MISS</acronym>
  <official_title>Phase IV Multicenter Infection Surveillance Study Following Colorectal Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Halyard Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Halyard Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a multicenter, open label, observational, postmarketing surveillance study of
      the ON-Q® Silver SoakerTM in the United States and Canada. This study was developed to
      investigate specific aspects of infection rates and hospital length of stay following routine
      use of this device in patients undergoing colorectal surgical procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a multicenter, open label, observational, postmarketing surveillance study of
      the ON-Q® Silver SoakerTM in the United States and Canada. This study was developed to
      investigate specific aspects of infection rates and hospital length of stay following routine
      use of this device in patients undergoing colorectal procedures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <primary_completion_date type="Actual">August 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>30 days postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>Average 1 week</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">289</enrollment>
  <condition>Surgical Wound Infection</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <description>Surgical site continuous local anesthetic infusion with ONQ silver Soaker System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Hospital standard of care for pain management (Patient controlled analgesia or epidural)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ON-Q Silver soaker System</intervention_name>
    <description>Continuous infusion of local anesthetic to surgical site</description>
    <arm_group_label>Active</arm_group_label>
    <other_name>Continuous surgical site local anesthetic infusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Patient controlled analgesia</intervention_name>
    <description>IV opioids delivered via PCA</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>PCA</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Surgical patients Colorectal procedures
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women, &gt;18 years of age;

          -  Scheduled for elective colon procedure;

          -  Ability to complete patient survey questionnaires;

          -  Provision of informed consent

        Exclusion Criteria:

          -  Patients with a prior allergic reaction to Morphine, Demerol, Dilaudid, Fentanyl,
             Marcaine (bupivacaine), lidocaine or Naropin (ropivacaine);

          -  Procedures for hemorrhoids;

          -  Inability to perform follow up assessments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jay Singh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Piedmont Medical Center</affiliation>
  </overall_official>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2008</study_first_submitted>
  <study_first_submitted_qc>September 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2008</study_first_posted>
  <last_update_submitted>March 17, 2015</last_update_submitted>
  <last_update_submitted_qc>March 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colorectal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

